» Articles » PMID: 39734821

E-cigarettes and Arterial Health: A Review of the Link Between Vaping and Atherosclerosis Progression

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have suggested an evolving understanding of the association between vaping, specifically electronic cigarette (e-cigarette) use, and the progression of atherosclerosis, a significant contributor to cardiovascular disease. Despite the prevailing perception of vaping as a safer alternative to traditional tobacco smoking, accumulating evidence suggests that the aerosols emitted by e-cigarettes contain harmful constituents that may promote endothelial dysfunction, oxidative stress, inflammation, and dyslipidemia-key mechanisms implicated in atherosclerosis pathogenesis. While past research, including experimental studies and clinical investigations, has shed light on the potential cardiovascular risks associated with vaping, gaps in knowledge persist. Future research endeavors should focus on interpreting the long-term effects of vaping on atherosclerosis development and progression, exploring the impact of different e-cigarette formulations and user demographics, and identifying effective strategies for mitigating the cardiovascular consequences of vaping. By identifying and addressing these research gaps, we can enhance our understanding of the cardiovascular implications of vaping and inform evidence-based interventions and policies to safeguard public health.

References
1.
Meehan-Atrash J, Luo W, McWhirter K, Strongin R . Aerosol Gas-Phase Components from Cannabis E-Cigarettes and Dabbing: Mechanistic Insight and Quantitative Risk Analysis. ACS Omega. 2019; 4(14):16111-16120. PMC: 6777088. DOI: 10.1021/acsomega.9b02301. View

2.
Shao B, Fu X, McDonald T, Green P, Uchida K, OBrien K . Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J Biol Chem. 2005; 280(43):36386-96. DOI: 10.1074/jbc.M508169200. View

3.
Gravely S, Fong G, Cummings K, Yan M, Quah A, Borland R . Awareness, trial, and current use of electronic cigarettes in 10 countries: Findings from the ITC project. Int J Environ Res Public Health. 2014; 11(11):11691-704. PMC: 4245638. DOI: 10.3390/ijerph111111691. View

4.
Jones K, Salzman G . The Vaping Epidemic in Adolescents. Mo Med. 2020; 117(1):56-58. PMC: 7023954. View

5.
Pirillo A, Norata G, Catapano A . LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013; 2013:152786. PMC: 3723318. DOI: 10.1155/2013/152786. View